New “pseudo cell” formulation could revolutionize treatment of vitreoretinal diseases

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Beijing Chaoyang Hospital have developed a new “pseudo cell” formulation based on self-healing microcapsule-loading exosomes to treat diverse vitreoretinal diseases.

Precision and TG Therapeutics conclude Azer-Cel license deal

Share this article Azercabtagene Zapreleucel will be developed for autoimmune diseases and other non-cancer indications. Credit: Peakstock / Shutterstock.com. Precision Biosciences and TG Therapeutics have

January 10, 2024

FDA approves Delcath’s liver-directed therapy for metastatic uveal melanoma – Pharmaceutical Technology

The Hepzato Kit has been approved in Europe since 2012 and is marketed as Chemosat hepatic delivery system for liver cancers. Image Credit: JHVEPhoto /

August 15, 2023

Medics Stand Ready to Aid Groundhog Day Crowds

When 30,000 visitors swarm Gobbler’s Knob around 4 a.m. today to watch a groundhog’s fleeting appearance, about 20 health providers from five responding organizations will

February 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.